Search

Health systems are changing continuously, due to powerful forces such as scientific and technical advances, social and economic conditions and demography. Change affects health systems by disrupting their internal balance, that is, the adjustment of supply and demand for healthcare. At a high level, the answer is to adopt a policy approach that covers and connects the three areas of patient experience, health outcomes and cost-effectiveness, similar to the "Triple Aim" or its numerous avatars. Closer to the action, at the level at which decisions about treatment or care are made, the current trend is to focus on the "value agenda.", (Copyright © 2020 Longwoods Publishing.)

Competing Interests: Competing interests: Marcello Tonelli received grants from the Canadian Institutes of Health Research (paid to institution). Pierre-Gerlier Forest provides advice to Norton Rose Fulbright LLP on health policy issues as part of a retainer agreement and has received consulting fees from Innovative Medicines Canada in that context. No other competing interests were declared.

Applications of behavioural economics to public policy are immediate and enlightening. In health policy, where we are exposed to a new fad every other month, it is not indifferent that we deal with a research program that is solidly grounded in decades of scholarship and that is supported by economic theory. Moreover, the experimental and realist bias of behavioural economics is attuned to our need for tested solutions and pragmatic improvements. Adam Oliver's paper is centred on methods that could incite people to make better, healthier lifestyle choices. But his approach can also help us formulate better regulations and smarter legislation. It can help us review the design of health organizations and care pathways. It encourages our efforts to properly use evidence and information. And finally, it forces us to examine the system of incentives and may even give someone the idea of looking at the underlying structure of power.

Canada's approach to shared decision making (SDM) is as disparate as its healthcare system; a conglomerate of 14 public plans at various administrative levels. SDM initiatives are taking place in different pockets of the country and are in different stages of development. The most advanced provincial initiative is occurring in Saskatchewan, where in 2010 the provincial government prepare to introduce patient decision aids into certain surgical specialties. With regard to decision support tools for patients, perhaps the most active entity is the Patient Decision Aids Research Group in Ottawa, Ontario. This group maintains a public inventory of decision aids ranked according to International Patient Decision Aid Standards and has developed the generic Ottawa Personal Decision Guide, as well as a toolkit for integrating decision aids in clinical practice. All of these tools are publicly available free of charge. Professional interest in SDM in Canada is not yet widespread, but Canada's principal health research funding agency is sponsoring several important SDM projects. Researchers from institutions across the country are promoting SDM through continuing professional development programs and other interventions in fields as varied as primary care, dietary medicine and workplace rehabilitation. Still, the future of SDM in Canada remains uncertain. Canada's provincially based structure obliges promoters to work with each province separately, and the recent growth of private healthcare risks dissipating efforts to implement SDM., (2011. Published by Elsevier GmbH.)

Although the costs of doctors' visits and hospital stays in Canada are covered by national public health insurance, the cost of outpatient prescription drugs is not. To solve problems of access, Canadian provinces have introduced provincial prescription drug benefit programs. This study analyzes the prescription drug policymaking process in five Canadian provinces between 1992 and 2004 with a view to (1) determining the federal government's role in the area of prescription drugs; (2) describing the policymaking process; (3) identifying factors in each province's choice of a policy; (4) identifying patterns in those factors across the five provinces; and (5) assessing the federal government's influence on the policies chosen. Analysis shows that despite significant differences in policy choices, the ideological motivations of the provinces were unexpectedly similar. The findings also highlight the importance of institutional factors, for example, in provinces' decision to compete rather than to collaborate. We conclude that, to date, Canada's federalism laboratory has only partly benefited the Canadian public. Cost pressures may, however, eventually overcome barriers to cooperation between the provincial and the federal governments, enabling them to capitalize on Canada's federal structure to improve the accessibility and affordability of drugs.

This article focuses on Quebec's most recent reform in the regionalization of health care to understand why the government chose to transform the regional boards into agencies. This case study used interviews and documentary analysis. Rooted in a political science perspective, the conceptual framework is inspired by the work of John Kingdon (1995) and draws on the four variables that influence the choice of policy: ideas, interests, institutions and events. Results of the case study suggest that Quebec's Commission of Study for Health and Social Services (the Clair Commission) in 2000 and the 2002 pre-electoral environment put the issue on the agenda. In 2003, the newly elected Liberal government passed Bill 25 – An Act Respecting Local Health and Social Services Network Development Agencies, which represented a political compromise: originally slated for eradication, the regional tier survived but in a new form. The element that sparked reform was the change in government following the elections. Different inquiry reports spread the reform's ideas, while interest groups articulated contrasting visions on the transformation. Above all, regional institutions showed great resilience in the face of change. From a historical perspective, this regionalization policy is a step backward: the regional tier is now stronger from a managerial and technocratic point of view, but it is politically and democratically weakened. This suggests a government intention, at that time, to maintain the regional level as a means of retaining centralized control over Quebec's health-care system.

A common thread weaving through the current public participation debate is the need for new approaches that emphasize two-way interaction between decision makers and the public as well as deliberation among participants. Increasingly complex decision making processes require a more informed citizenry that has weighed the evidence on the issue, discussed and debated potential decision options and arrived at a mutually agreed upon decision or at least one by which all parties can abide. We explore the recent fascination with deliberative methods for public involvement first by examining their origins within democratic theory, and then by focusing on the experiences with deliberative methods within the health sector. In doing so, we answer the following questions "What are deliberative methods and why have they become so popular? What are their potential contributions to the health sector?" We use this critical review of the literature as the basis for developing general principles that can be used to guide the design and evaluation of public involvement processes for the health-care sector in particular.

This paper is centred on the use of legislation as a tool of public action in health policy. We suggest that, as with the Canada Health Act (CHA) of 1984, this option should be considered to direct future reform efforts and pursue our collective aims of health and wellness. The CHA is the legislative expression of the federal government's exercise of its spending power, serving to consolidate key national agreements governing the circumstances under which the federal government contributes to the costs of medically necessary health services delivered by the provinces and territories. Two features of the CHA merit highlighting. The first is that its core provisions -- in particular, the five criteria often referred to as Canada's "national standards" for health care -- were not new or original to the CHA. The CHA was nonetheless an important step in the development of Canada's health system because it enshrined together, in one statute, longstanding commitments. A second feature of the CHA worth highlighting is that it does not stand alone. The CHA is one of 13 statutes across the country, including one in each province and territory, that serve together to establish the basic legal infrastructure of Canada's health insurance system. The CHA's powers to make regulations and issue policy interpretation letters offer important potential to achieve needed health system reforms without needing to "open" the act. Even where these powers are unrestricted by an express requirement for consultation with the provinces and territories, however, this would undoubtedly be required, given the fundamentally consensual nature of the CHA. Finally, the federal government's legislative options are not limited to the CHA. Jurisdiction over health and health care in Canada is shared between the federal and provincial and territorial governments. The various federal powers with health aspects allocated by the Constitution Act, 1867 are significant, including the residual "federal health power" to make laws "for the peace, order and good government of Canada" It therefore makes good sense to consider federal policy objectives in the health domain with regard for the full spectrum of federal legislative competence. [ABSTRACT FROM AUTHOR]

"Health in All Policies" (HiAP) is an approach that systematically considers the health and social implications of policies contemplated by all sectors of government - aiming for synergistic benefits and to minimize social and health-related harms. Although no data on definitive health outcomes are yet available, HiAP implementation has become widespread, comprehensive and systematic in China, driven by strong political commitment, stable funding, and considerable support from the national health commission and local government. Clinicians, in their roles as community leaders, can advocate for the importance of HiAP in addressing the social determinants of health while delivering wide-ranging benefits beyond the health sector, and teach the potential value of HiAP to undergraduate and graduate physicians in training. [Extracted from the article]

In the fall of 2014, the Government of Canada formally split the role of the Chief Public Health Officer (CPHO) into two positions: the CPHO and the President of the Public Health Agency of Canada. Despite concerns raised by the public health community, these changes are consistent with the CPHO's authority. However, the nature of responsible government means that the CPHO cannot simultaneously serve as an independent advocate for policies and programs that might prevent disease and as a senior advisor to the government of the day. [ABSTRACT FROM AUTHOR]

An introduction is presented in which the guest editors discuss essays and papers in the journal's special issue pertaining to real reform in health care systems.

Copyright of International Political Science Review is the property of Sage Publications, Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

In January 1997, the government of Quebec, Canada, implemented a public/private prescription drug program that covered the entire population of the province. Under this program, the public sector collaborates with private insurers to protect all Quebecers from the high cost of drugs. This article outlines the principal features and history of the Quebec plan and draws parallels between the factors that led to its emergence and those that led to the passage of the Medicare Prescription Drug, Improvement and Modernization Act (MMA) in the United States. It also discusses the challenges and similarities of both programs and analyzes Quebec's ten years of experience to identify adjustments that may help U.S. policymakers optimize the MMA. [ABSTRACT FROM AUTHOR]

The article discusses the concept of public deliberation and that is value-based in that it seeks to determine what ought to be done in response to a particular issue or a challenge that requires citizens to identify, clarify, and weigh the tensions among their views and the values underlying them; justify them to others; and set priorities. The need to understand that public deliberation is especially transformative wherein insight is gained is highlighted.

Among the many reasons that may limit the adoption of promising reform ideas, policy capacity is the least recognized. The concept itself is not widely understood. Although policy capacity is concerned with the gathering of information and the formulation of options for public action in the initial phases of policy consultation and development, it also touches on all stages of the policy process, from the strategic identification of a problem to the actual development of the policy, its formal adoption, its implementation, and even further, its evaluation and continuation or modification. Expertise in the form of policy advice is already widely available in and to public administrations, to well-established professional organizations like medical societies and, of course, to large private-sector organizations with commercial or financial interests in the health sector. We need more health actors to join the fray and move from their traditional position of advocacy to a fuller commitment to the development of policy capacity, with all that it entails in terms of leadership and social responsibility. [ABSTRACT FROM AUTHOR]